National Institute for Health and Clinical Excellence (NICE)

The NHS is to focus resources on adults who are obese and can improve their health by losing even a small amount of weight if they keep it off, according to health watchdog NICE.

A new cancer drug which targets secondary breast cancer has been rejected by the National Institute of Clinical Excellence (NICE) due to its high cost.

NICE, the healthcare guidance body, has issued draft guidance recommending enzalutamide (Xtandi, Astellas Pharma) as an option for treating hormone relapsed metastatic prostate cancer in adults.

The National Institute for Health and Care Excellence (NICE) is updating clinical guideline on the diagnosis and treatment prostate cancer.

At risk women across England and Wales could be given a daily pill to prevent breast cancer.

The Department of Health (DH) is "seeking views" on a cut in medical drug prices of between 10% and 20% and changing how drugs are assessed for value.

The National Institute for Health and Care Excellence (NICE) has advised the NHS against funding for a drug used for advanced ovarian cancer.

The health and social care body NICE has opened consultation on draft guidance to help people stop smoking in secondary care, with a focus on acute mental health services and maternity.

Patient experience software has been launched in a bid to support healthcare providers in managing, monitoring and analysing online surveys in line with government targets.

Treatment final guidance has been published for sufferers of common heart conditions.